Literature DB >> 32876387

Impact of bile acids on the severity of laryngo-pharyngeal reflux.

Eugenio De Corso1, Silvia Baroni2, Giampiero Salonna1, Michele Marchese3, Marilena Graziadio4, GIovanni Di Cintio1, Gaetano Paludetti1, Guido Costamagna5, Jacopo Galli1.   

Abstract

OBJECTIVES: The primary end point of this study was to evaluate the impact of bile acids on severity of laryngo-pharyngeal reflux (LPR) and the possible correlation with esophagitis and upper airway malignancies. The second end point was to evaluate if salivary bile acids and molecules other than pepsin might serve as diagnostic biomarkers of LPR.
DESIGN: Observational prospective comparative study.
SETTING: Otorhinolaryngology unit of a tertiary hospital. PARTICIPANTS: Sixty-two consecutive adult outpatients suspected of LPR. MAIN OUTCOME MEASURES: Bile acids, bilirubin and pepsinogen I-II were measured in saliva. Patients underwent pH metry and based on the results of bile acids were subdivided as acid, mixed and alkaline LPR.
RESULTS: Significantly higher Reflux Findings Score (RFS) and Reflux Symptoms Index (RSI) were seen in patients with alkaline and mixed LPR compared to acid LPR. Salivary bile acids >1 µmol/L seem to be a reliable indicator of the severity of LPR. Compared to those without, patients with esophagitis or a history of upper airway malignancy have high concentrations of bile acids in saliva. Among the molecules studied, bile acids were the most suitable for diagnosis of LPR, with a sensitivity of 86% and a positive predictive value of 80.7%.
CONCLUSIONS: Our data suggest that high concentrations of bile acids are associated with higher values of RSI and RFS in LPR as well as a higher risk of esophagitis and history of upper airway malignancies. We finally observed that bile acids provided the best biometric parameters for diagnosis of LPR among the molecules tested.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  bile acids; bile reflux; bilirubin; laryngo-pharyngeal reflux; pepsin; pepsinogen; saliva

Mesh:

Substances:

Year:  2020        PMID: 32876387     DOI: 10.1111/coa.13643

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  5 in total

1.  The study of laryngopharyngeal reflux needs adequate animal model.

Authors:  Jerome R Lechien; Christian Calvo-Henriquez; Miguel Mayo-Yanez; Mariam El Ayoubi; Luigi A Vaira; Antonino Maniacci
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-19       Impact factor: 2.503

2.  The importance of 24-h hypopharyngeal-esophageal impedance-pH monitoring for the treatment of laryngopharyngeal reflux.

Authors:  Robin Baudouin; Christian Calvo-Henriquez; Miguel Mayo-Yanez; Giannicola Iannella; Antonino Maniaci; Jerome R Lechien
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-25       Impact factor: 3.236

3.  In response to the importance of 24-h hypopharyngeal-esophageal impedance-pH monitoring for the treatment of laryngopharyngeal reflux.

Authors:  Jinhong Zhang; Xiaoyu Wang; Jiasen Wang; Jing Zhao; Chun Zhang; Zhi Liu; Jinrang Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-27       Impact factor: 3.236

Review 4.  Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians.

Authors:  Jerome R Lechien; Sven Saussez; Vinciane Muls; Maria R Barillari; Carlos M Chiesa-Estomba; Stéphane Hans; Petros D Karkos
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

Review 5.  Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.

Authors:  Yading Li; Gaofan Xu; Bingduo Zhou; Yishuang Tang; Xiaowen Liu; Yue Wu; Yi Wang; Jing Kong; Tingting Xu; Cong He; Shengliang Zhu; Xiaosu Wang; Jianning Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-12-03       Impact factor: 3.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.